Latest

09:26
【ZIJIN GOLD INTL(02259.HK)2026 Interim Report - Profit Attributable to Shareholders stood at USD 1.45 billion, YoY increase of 178.83%】NewTimeSpace (newtimespace.com) News,August 16, 2026, ZIJIN GOLD INTL(02259.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 3.99 billion, increased by 99.67% YoY
Tag： ZIJIN GOLD INTL02259.HKNewTimeSpace
09:25
【Suzhou Canmax Technologies: receives CSRC supplementary filing requirements for its Hong Kong listing, with 6 items queried including energy-intensity review of fund-raising projects and CATL related-party transactions】NewTimeSpace News: On 14 August 2026, the CSRC International Department issued supplementary filing requirements to Suzhou Canmax Technologies for its overseas listing, requiring supplementary explanations and legal opinions on 6 items including whether the fund-raising projects are "high energy consumption" or "high emission" projects, the fairness of related-party transactions with CATL, pending litigation and arbitration, and the necessity of the Hong Kong listing.
Tag： SUZHOU CANMAXIPOSupplementary Materials for Filing
09:22
【GENSCRIPT BIO(01548.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of USD 129.34 million, loss widened by 407.98% YoY】NewTimeSpace (newtimespace.com) News, August 16, 2026, GENSCRIPT BIO(01548.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 404.22 million, decreased by 22.08% YoY
Tag： GENSCRIPT BIO01548.HKNewTimeSpace
09:21
【YESMRO: CSRC International Department issues supplementary filing requirements for its overseas listing, covering 8 items】NewTimeSpace News: On 14 August 2026, the CSRC International Department issued supplementary filing requirements to YESMRO Holdings Limited for its overseas listing, requiring supplementary explanations and legal opinions on 8 items including round-trip M&A compliance, new shareholders within the last 12 months, control identification, shareholder look-through and nominee shareholding, and equity incentives; the regulator specifically requires verification of the share repurchase and transfer in January 2026, the look-through of 5% shareholder Shanghai Lingyi and historical nominee shareholding arrangements.
Tag： YESMROIPOSupplementary Materials for Filing
09:18
【Ruike Xianjin: CSRC International Department issues supplementary filing requirements for its overseas listing, covering 7 items】NewTimeSpace News: On 14 August 2026, the CSRC International Department issued supplementary filing requirements to Ruike Xianjin for its overseas listing, requiring supplementary explanations and legal opinions on 7 items including round-trip M&A compliance, the restructuring progress of Ruihua Xindian, joint actual controller determination, nominee shareholding and equity incentives.
Tag： Ruike XianjinIPOSupplementary Materials for Filing
08:55
【YNBY INTL(00030.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 2.69 million, YoY increase of 13.31%】NewTimeSpace News: August 14, 2026, YNBY INTL(00030.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 762.54 million, increased by 92.34% YoY.
Tag： YNBY INTL00030.HKprofit growth
08:54
【PALINDA GROUP(08179.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 1.15 million, turned into a loss from a profit YoY】NewTimeSpace News: August 14, 2026, PALINDA GROUP(08179.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 64.34 million, decreased by 0.04% YoY.
Tag： PALINDA GROUP08179.HKturned into a loss from a profit
08:52
【CH DEMETER FIN(08120.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 10.65 million, loss narrowed by 39.65% YoY】NewTimeSpace News: August 14, 2026, CH DEMETER FIN(08120.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 24.35 million, decreased by 52.96% YoY.
Tag： CH DEMETER FIN08120.HKloss narrowed
08:51
【SANDS CHINA LTD(01928.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 398 million, YoY decrease of 3.63%】NewTimeSpace News: August 14, 2026, SANDS CHINA LTD(01928.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 3.88 billion, increased by 11.08% YoY.
Tag： SANDS CHINA LTD01928.HKProfit declined
08:48
【NU ENVIRO(00436.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 11.71 million, loss widened by 10.23% YoY】NewTimeSpace News: August 14, 2026, NU ENVIRO(00436.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 181.02 million, increased by 9.63% YoY.
Tag： NU ENVIRO00436.HKLoss widens
08:44
【SEM HLDGS(09929.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 53.41 million, turned into a loss from a profit YoY】NewTimeSpace News: August 14, 2026, SEM HLDGS(09929.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 38.78 million, increased by 80% YoY.
Tag： SEM HLDGS09929.HKturned into a loss from a profit
08:43
【SING LEE(08076.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 8.44 million, loss widened by 10.22% YoY】NewTimeSpace News: August 14, 2026, SING LEE(08076.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 20.6 million, increased by 13.2% YoY.
Tag： SING LEE08076.HKLoss widens
08:42
【KAM HING INT'L(02307.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 13.74 million, YoY increase of 114.38%】NewTimeSpace News: August 14, 2026, KAM HING INT'L(02307.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 1.77 billion, decreased by 3.7% YoY.
Tag： KAM HING INTL02307.HKprofit growth
08:40
【XIAOCAIYUAN(00999.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 289.84 million, YoY decrease of 24.2%】NewTimeSpace News: August 14, 2026, XIAOCAIYUAN(00999.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 2.9 billion, increased by 6.96% YoY.
Tag： XIAOCAIYUAN00999.HKProfit declined
08:39
【B&K CORP-B(02396.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 121.92 million, loss widened by 40.65% YoY】NewTimeSpace News: August 14, 2026, B&K CORP-B(02396.HK) released its Interim Report for the period ended December 31, 2026.
Tag： B&K CORP-B02396.HKLoss widens
08:37
【INSILICO (03696.HK): to be included in MSCI Global Small Cap Index, effective after market close on 31 August】NewTimeSpace News: On 17 August 2026, InSilico Medicine (03696.HK) voluntarily announced that it will be included in the MSCI Global Small Cap Index, effective after the market close on 31 August 2026; the Company had previously been included in several major index series including CSI, Hang Seng and FTSE, and the Board expects the inclusion to raise its international profile and attract passive fund inflows.
Tag： Insilico Medicine03696.HKMSCIIndex Inclusion
08:32
【HENLIUS (02696.HK): enters global strategic partnership with Sandoz covering up to 10 biosimilar products, with upfront and milestone payments totaling up to USD 314 million】NewTimeSpace News: On 17 August 2026, Henlius (02696.HK) announced that on 16 August 2026 it entered into a cooperation framework agreement with Sandoz, establishing a global strategic partnership covering up to 10 mAb and/or ADC biosimilar products in territories excluding Mainland China and Hong Kong, Macao and Taiwan regions of China; for the first batch of three products, upfront and milestone payments total up to USD 314 million, plus a 40% share of net sales or net profits and a USD 8 million option fee.
Tag： HENLIUS02696.HKstrategic cooperation
08:20
【HUTCHMED (00013.HK): ORPATHYS® + TAGRISSO® combination shows statistically and clinically meaningful PFS and OS improvement in MET-driven EGFR-mutated lung cancer】NewTimeSpace News: On 17 August 2026, HUTCHMED (00013.HK) announced positive topline results from the SAFFRON Phase III study of ORPATHYS® plus TAGRISSO® in MET-driven EGFR-mutated NSCLC, showing statistically significant and clinically meaningful improvements in both PFS and OS, the first global Phase III trial in this setting to show significant benefit on both endpoints; the combination was well tolerated, and the data will be shared with global regulatory authorities to support global registration of the regimen.
Tag： HUTCHMED00013.HKClinical Trial
08:15
【TSIT WING INTL(02119.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 23.7 million, YoY decrease of 4.66%】NewTimeSpace News: August 14, 2026, TSIT WING INTL(02119.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 398.43 million, increased by 4.73% YoY.
Tag： TSIT WING INTL02119.HKProfit declined
08:13
【SINOFORTUNE FIN(08123.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 5.91 million, turned into a loss from a profit YoY】NewTimeSpace News: August 14, 2026, SINOFORTUNE FIN(08123.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 46.06 million, increased by 923.35% YoY.
Tag： SINOFORTUNE FIN08123.HKturned into a loss from a profit
Previous1..7576 777879..488     488 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments